In neurodegenerative diseases, the effect of blocking anti-PD-1/PD-L1 on mitigating brain pathology was associated with evoking an immune response in the periphery (outside the brain) which induced recruitment of specialized immune cells to the brain’s territory. Here, CD274 is linked to neurodegenerative disease.